Matrix-binding vesicles (MBVs) for treating acute respiratory distress syndrome

Disclosed are methods of treating acute respiratory distress syndrome (e.g., acute respiratory distress syndrome associated with viral infection, e.g., SARS-CoV2 (COVID-19)) in a subject in need thereof. The methods include administering to a subject a pharmaceutical formulation comprising isolated...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HUSSEY GEORGE S, KRUMM, RALF, BADYLAK STEPHEN FRANCIS
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed are methods of treating acute respiratory distress syndrome (e.g., acute respiratory distress syndrome associated with viral infection, e.g., SARS-CoV2 (COVID-19)) in a subject in need thereof. The methods include administering to a subject a pharmaceutical formulation comprising isolated matrix-binding vesicles (MBVs) derived from an extracellular matrix. 公开了治疗有需要的受试者的急性呼吸窘迫综合征(例如病毒感染相关的急性呼吸窘迫综合征，例如SARS-CoV2(COVID-19))的方法。这些方法包括向受试者施用药物制剂，该药物制剂包含源自细胞外基质的分离的基质结合囊泡(MBV)。